EP 898B Understanding Your Inhaler

Guest Bio: Nicola A. Hanania, MD, MS

Nicola A. Hanania, MD, MS, is Associate Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and Director of the American Lung Association Airways Clinical Research Center (ACRC) at the Baylor College of Medicine.

Dr. Hanania completed his medical training at the University of Jordan followed by residency in internal medicine and fellowship in pulmonary medicine at the University of Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master's degree in clinical investigation.

As a Fellow of the American College of Chest Physicians (ACCP), Dr. Hanania has served on the Board of Regents and as Chair of the ACCP's Clinical Pulmonary, Airways Networks and Council of Networks. He has been a member of Board of Trustees of the Chest Foundation since 2012. Additionally, he is a current member of the Health Policy Committee of the American Thoracic Society (ATS), the European Respiratory Society (ERS), the Society of Critical Care Medicine and a fellow of the Royal College of Physicians and Surgeons of Canada. He has served on several guideline and workshop panels including the ACP/ATS/ACCP/ERS Clinical Practice guidelines on chronic obstructive pulmonary disease (COPD) and the CTS/ACCP COPD exacerbations guidelines.

Dr. Hanania has received multiple awards including the ACCP's Distinguished Scholar in Respiratory Health, ACCP Humanitarian Award, a Career Investigator Award (K23) from the NIH, a Fulbright, Jaworski's Faculty Excellence Award for Teaching and Evaluation and the Award for Excellence in Teaching from the Baylor Department of Medicine. Dr. Hanania is a deputy editor of Respiratory Medicine and is Associate Editor of Therapeutic Advances in Respiratory Disease, Current Opinion in Pulmonary Medicine (Asthma Section) and Pulmonary Pharmacology and Therapeutics.

Dr. Hanania's research interests focus on the pharmacology and management of asthma and COPD. He has published more than 200 peer-reviewed papers, book chapters, editorials and reviews on these topics. He is actively involved in clinical trials research, investigating novel treatments.